HCWB: HCW Biologics Inc O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
HCW Biologics Inc. (HCWB) protein litsenziyalash uchun patent himoyasini yo'lga qo'ygan holda TOBI immunoterapiya tizimini ishlab chiqmoqda. Ushbu grafik GURU.Markets portalidagi peg_co multiplikator qiymatini aks ettiradi, bunda 0.00 ko'rsatkichi eng so'nggi darajani ifodalaydi. Biznes modeli ishlab chiqarish va sinovlarni autsorsing qilishga asoslangan, moliyaviy barqarorlik esa hozirda barqaror operatsion pul oqimi mavjud emasligi sababli ventura kapitali oligarchik injeksiyalariga bog'liq.
HCW Biologics Inc. (HCWB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi hcwbiologics.com|HCWB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar HCW Biologics Inc|HCWB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari HCW Biologics|Tezkor likvidlik ko‘rsatkichi hcwbiologics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
HCWB - Sof daromad|Kelajakdagi foyda HCW Biologics Inc.|HCWB - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori hcwbiologics.com|HCWB - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati HCW Biologics Inc|HCWB - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda HCW Biologics|HCWB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi hcwbiologics.com|HCWB - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi HCW Biologics Inc.
Kompaniyaning umumiy tahlili:HCWB - HCW Biologics, Inc.
HCW Biologics Inc. (HCWB) kompaniyasining immunoterapiya sohasidagi patentlarining yuqori masshtablanuvchanligi litsenziyalash daromadlarining eksponensial o'sishi uchun imkoniyat yaratadi. Tarixiy PEG koeffitsiyentini tahlil qilish orqali investor aksiyalarning bozor qiymatini foyda o'sish sur'ati bilan solishtiradi: birdan past qiymat aktivning qadrini past baholaganini anglatadi va bu sanoat sikllaridagi o'zgarishlar davrida bozorning kompaniyaning texnologik ustunligidan foydalanishga tayyorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PHVS (Pharvaris Pharma)|ABCL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|Narx-foyda va o‘sish multiplikatori PGEN|Narx-foyda va o‘sish multiplikatori Pharming Group NV (PHAR)|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|Narxning foydaga va o‘sish sur’atiga nisbati RIGL|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ENGN (enGene Bio)|Narxning sof foyda o‘sishiga nisbati rapt.com|Aerovate - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aclaristx.com ACRS|KYTX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori THTX (Theratechnologies Inc.)|AVTX (avalotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|ZURA (zurabio.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Adagene Inc.|Narx-foyda va o‘sish multiplikatori IMA|Shattuck Therapeutics (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori EQ|CNTB (connectbiopharm.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori IMUX (Immunic)|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX: Narx-foyda va o‘sish multiplikatori|X4 Pharmaceuticals Inc. (XFOR) - Narx-foyda va o‘sish multiplikatori|ACET: PEG multiplikatori|CELU (Celularity) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|barinthusbio.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori KZR|SABS (SAB Biotherapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AKTX (Akari Therapeutics plc)|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GOVX (geovax.com)|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori iBio Inc|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|PEG multiplikatori XTL Bio|Narx-foyda va o‘sish multiplikatori BOLT (Bolt Biotherapeutics)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narx-foyda va o‘sish multiplikatori INDP|PEG multiplikatori Scinai Immunotherapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|affimed.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - O‘sish sur’atiga tuzatilgan narx-foyda|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|Narx-foyda va o‘sish multiplikatori THRD
